GlobeNews Wire

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

June 16, 2025 19:20 ET  | Source: PolyPid Ltd. The Company Anticipates that with this Additional Funding, PolyPid’s Runway would…

10 months ago

Dr. Elad Yossefi and Dr. Tal Yossefi Introduce Tech-Enhanced Dental Services in Norwalk

Norwalk, CT / USA, June 16, 2025 (GLOBE NEWSWIRE) -- Norwalk, CT — Advanced Dental Center in Norwalk, Connecticut, led…

10 months ago

Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results

June 16, 2025 18:40 ET  | Source: Enzo Biochem, Inc. FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem,…

10 months ago

OTOFIX Introduces the D1 Lite Diagnostic Tool, Purpose-Built for Small Garage Technicians

Shenzhen, China, June 16, 2025 (GLOBE NEWSWIRE) -- OTOFIX has just introduced the D1 Lite, a compact diagnostic tool designed for small…

10 months ago

Power Queen’s Father’s Day Hot Battery Offer Opens for a Limited Time

Shenzhen, China, June 16, 2025 (GLOBE NEWSWIRE) -- To Celebrate the Father's Day, Power Queen is still offering a special limited…

10 months ago

Kaleris and Port of Tanjung Pelepas Recognized for Advancement Optimization With 2025 Top Supply Chain Projects Award

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Kaleris, a leading provider of supply chain execution software, and Port of Tanjung…

10 months ago

Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage…

10 months ago

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical…

10 months ago

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever…

10 months ago

XRP News: Vaultro Finance Presale on XRP ledger Skyrockets Past 50%, As Investors Race to Own $VLT Token

SINGAPORE , June 15, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has just announced a landmark achievement in its public sale…

10 months ago